Cancer Communications (Aug 2021)
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
- Feng‐Hua Wang,
- Xiao‐Tian Zhang,
- Yuan‐Fang Li,
- Lei Tang,
- Xiu‐Juan Qu,
- Jie‐Er Ying,
- Jun Zhang,
- Ling‐Yu Sun,
- Rong‐Bo Lin,
- Hong Qiu,
- Chang Wang,
- Miao‐Zhen Qiu,
- Mu‐Yan Cai,
- Qi Wu,
- Hao Liu,
- Wen‐Long Guan,
- Ai‐Ping Zhou,
- Yu‐Jing Zhang,
- Tian‐Shu Liu,
- Feng Bi,
- Xiang‐Lin Yuan,
- Sheng‐Xiang Rao,
- Yan Xin,
- Wei‐Qi Sheng,
- Hui‐Mian Xu,
- Guo‐Xin Li,
- Jia‐Fu Ji,
- Zhi‐Wei Zhou,
- Han Liang,
- Yan‐Qiao Zhang,
- Jing Jin,
- Lin Shen,
- Jin Li,
- Rui‐Hua Xu
Affiliations
- Feng‐Hua Wang
- Department of Medical Oncology State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- Xiao‐Tian Zhang
- Department of Gastrointestinal Oncology Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
- Yuan‐Fang Li
- Department of Gastric Surgery State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- Lei Tang
- Department of Radiology Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
- Xiu‐Juan Qu
- Department of Medical Oncology The First Hospital of China Medical University Shenyang Liaoning 110001 P. R. China
- Jie‐Er Ying
- Department of Medical Oncology Zhejiang Cancer Hospital Hangzhou Zhejiang 310006 P. R. China
- Jun Zhang
- Department of Medical Oncology Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai 200025 P. R. China
- Ling‐Yu Sun
- Department of Surgical Oncology The Fourth Affiliated Hospital of Harbin Medical University Harbin Heilongjiang 150001 P. R. China
- Rong‐Bo Lin
- Department of Medical Oncology Fujian Cancer Hospital Fuzhou Fujian 350000 P. R. China
- Hong Qiu
- Department of Medical Oncology Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei 430030 P. R. China
- Chang Wang
- Cancer Center of The First Hospital of Jilin University Changchun Jilin 130021 P. R. China
- Miao‐Zhen Qiu
- Department of Medical Oncology State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- Mu‐Yan Cai
- Department of Pathology State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- Qi Wu
- Department of Endoscopy Center Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
- Hao Liu
- Department of General Surgery Nanfang Hospital Southern Medical University Guangzhou Guangdong 510515 P. R. China
- Wen‐Long Guan
- Department of Medical Oncology State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- Ai‐Ping Zhou
- Department of Oncology National Cancer Center National Clinical Research Center for Cancer Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. China
- Yu‐Jing Zhang
- Department of Radiotherapy State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- Tian‐Shu Liu
- Department of Medical Oncology Zhongshan Hospital Affiliated to Fudan University Shanghai 200032 P. R. China
- Feng Bi
- Department of Abdominal Oncology West China Hospital of Sichuan University Chengdu Sichuan 610041 P. R. China
- Xiang‐Lin Yuan
- Department of Medical Oncology Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei 430030 P. R. China
- Sheng‐Xiang Rao
- Department of Radiology Zhongshan Hospital Fudan University Shanghai 200032 P. R. China
- Yan Xin
- Pathology Laboratory of Gastrointestinal Tumor The First Hospital of China Medical University Shenyang Liaoning 110001 P. R. China
- Wei‐Qi Sheng
- Department of Pathology Zhongshan Hospital Affiliated to Shanghai Fudan University Shanghai 200032 P. R. China
- Hui‐Mian Xu
- Department of Gastrointestinal Oncology Surgery The First Hospital of China Medical University Shenyang Liaoning 110001 P. R. China
- Guo‐Xin Li
- Department of General Surgery Nanfang Hospital Southern Medical University Guangzhou Guangdong 510515 P. R. China
- Jia‐Fu Ji
- Department of Gastrointestinal Surgery Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
- Zhi‐Wei Zhou
- Department of Gastric Surgery State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- Han Liang
- Department of Gastric Surgery Tianjin Medical University Cancer Institute & Hospital Tianjin 300060 P. R. China
- Yan‐Qiao Zhang
- Department of Gastrointestinal Medical Oncology Cancer Hospital of Harbin Medical University Harbin Heilongjiang 150081 P. R. China
- Jing Jin
- Department of Radiation Oncology Shenzhen Center Cancer Hospital of Chinese Academy of Medical Sciences Shenzhen 518000 P. R. China
- Lin Shen
- Department of Gastrointestinal Oncology Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
- Jin Li
- Department of Oncology East Hospital Affiliated to Shanghai Tongji University Shanghai 200120 P. R. China
- Rui‐Hua Xu
- Department of Medical Oncology State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou Guangdong 510060 P. R. China
- DOI
- https://doi.org/10.1002/cac2.12193
- Journal volume & issue
-
Vol. 41,
no. 8
pp. 747 – 795
Abstract
Abstract There exist differences in the epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selections between gastric cancer patients from the Eastern and Western countries. The Chinese Society of Clinical Oncology (CSCO) has organized a panel of senior experts specializing in all sub‐specialties of gastric cancer to compile a clinical guideline for the diagnosis and treatment of gastric cancer since 2016 and renews it annually. Taking into account regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted expert consensus judgment on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes in China. The 2021 CSCO Clinical Practice Guidelines for Gastric Cancer covers the diagnosis, treatment, follow‐up, and screening of gastric cancer. Based on the 2020 version of the CSCO Chinese Gastric Cancer guidelines, this updated guideline integrates the results of major clinical studies from China and overseas for the past year, focused on the inclusion of research data from the Chinese population for more personalized and clinically relevant recommendations. For the comprehensive treatment of non‐metastatic gastric cancer, attentions were paid to neoadjuvant treatment. The value of perioperative chemotherapy is gradually becoming clearer and its recommendation level has been updated. For the comprehensive treatment of metastatic gastric cancer, recommendations for immunotherapy were included, and immune checkpoint inhibitors from third‐line to the first‐line of treatment for different patient groups with detailed notes are provided.
Keywords
- adjuvant
- chemotherapy
- Chinese Society of Clinical Oncology (CSCO)
- diagnosis
- gastric cancer
- immunotherapy
